Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P-aeruginosa infection

被引:17
作者
Chen, TY
Shang, HF
Chen, TL
Lin, CP
Hui, CF
Hwang, J [1 ]
机构
[1] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan
[2] Natl Yang Ming Univ, Sch Life Sci, Inst Genet, Taipei 115, Taiwan
[3] Acad Sinica, Inst Zool, Taipei 115, Taiwan
[4] Coll Med, Dept Microbiol, Taipei, Taiwan
[5] Dept Hlth, Natl Labs Foods & Drugs, Div Drug Biol, Taipei, Taiwan
关键词
D O I
10.1007/s002530051555
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have constructed a chimeric protein composed of the receptor binding and membrane translocation domains of Pseudomonas exotoxin A (PE) with the outer membrane proteins I and F, together designated as PEIF. The potential of PEIF as a vaccine against Pseudomonas infection was evaluated in BALB/c mice and New Zealand white rabbits. We examined titers of anti-PE and anti-OprF antibodies, and the ability both to neutralize PE cytotoxicity and to increase opsonophagocytic uptake of Pseudomonas aeruginosa strain PAO1, serogroups 2 and 6. The results showed that PEIF can induce antibodies not only to neutralize the PE cytotoxicity but also to promote the uptake of various strains of P. aeruginosa by murine peritoneal macrophages. In a burned mouse model, PEIF afforded significant protection against infection by the homologous P. aeruginosa strain PAO1, heterologous serogroup 2, and the PE hyperproducing strain PA103. These observations thus indicate that PEIF may be used as a novel vaccine against P. aeruginosa infection.
引用
收藏
页码:524 / 533
页数:10
相关论文
共 42 条
[1]  
ABE C, 1975, JPN J EXP MED, V45, P355
[2]  
BODEY GP, 1983, REV INFECT DIS, V5, P279
[3]   ANTIGENIC DETERMINANTS OF MUREIN LIPOPROTEIN AND ITS EXPOSURE AT SURFACE OF ENTEROBACTERIACEAE [J].
BRAUN, V ;
BOSCH, V ;
KLUMPP, ER ;
NEFF, I ;
MAYER, H ;
SCHLECHT, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1976, 62 (03) :555-566
[4]  
CHOW JT, 1989, J BIOL CHEM, V264, P18818
[5]  
CLEMENT WF, 1994, CHEST, V105, P1545
[6]  
Cryz S., 1984, BACTERIAL VACCINES, P317
[7]   OCTAVALENT PSEUDOMONAS-AERUGINOSA O-POLYSACCHARIDE-TOXIN-A CONJUGATE VACCINE [J].
CRYZ, SJ ;
SADOFF, JC ;
FURER, E .
MICROBIAL PATHOGENESIS, 1989, 6 (01) :75-80
[8]   SAFETY AND IMMUNOGENICITY OF A PSEUDOMONAS-AERUGINOSA O-POLYSACCHARIDE TOXIN A CONJUGATE VACCINE IN HUMANS [J].
CRYZ, SJ ;
FURER, E ;
CROSS, AS ;
WEGMANN, A ;
GERMANIER, R ;
SADOFF, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :51-56
[9]   PROTECTION AGAINST FATAL PSEUDOMONAS-AERUGINOSA BURN WOUND SEPSIS BY IMMUNIZATION WITH LIPOPOLYSACCHARIDE AND HIGH-MOLECULAR-WEIGHT POLYSACCHARIDE [J].
CRYZ, SJ ;
FURER, E ;
GERMANIER, R .
INFECTION AND IMMUNITY, 1984, 43 (03) :795-799
[10]   VACCINE POTENTIAL OF PSEUDOMONAS-AERUGINOSA O-POLYSACCHARIDE TOXIN-A CONJUGATES [J].
CRYZ, SJ ;
LANG, AB ;
SADOFF, JC ;
GERMANIER, R ;
FURER, E .
INFECTION AND IMMUNITY, 1987, 55 (07) :1547-1551